These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4762828)

  • 1. [The lipid reducing action of phenformin in primary type IV hyperlipoproteinaemia (author's transl)].
    Lang PD; Vollmar J; Klemens UH; von Löwis P; Gries FA; Koschinsky T; Huth K; Pilz E; Schlierf G; Kremer GJ; Lenhart P; Schwandt P; Hammerl H; Studlar M
    Dtsch Med Wochenschr; 1973 Nov; 98(48):2280-6. PubMed ID: 4762828
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].
    Koschinsky T; Lenhard P; Gries FA; Vogelberg KH; Wolfram G; Lang PD; Vollmar J
    Med Klin; 1977 Sep; 72(38):1537-43. PubMed ID: 904549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucose tolerance, insulin and lipids after one week's administration of fenfluramine to overweight patients (author's transl)].
    Weisweiler P; Schwandt P
    MMW Munch Med Wochenschr; 1975 Nov; 117(48):1925-8. PubMed ID: 813120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the clinical use of biguanides].
    Haese E
    Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination].
    Beringer A
    Minerva Med; 1974 Sep; 65(60):3127-39. PubMed ID: 4214043
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbohydrate metabolism in various types of hyperlipoproteinaemia.
    Romics L; Stützel M; Balázsi I; Varsányi-Nagy M
    Acta Med Acad Sci Hung; 1976; 33(3):225-32. PubMed ID: 1031550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of phenformin hydrochloride on serum cholesterol, triglycerides and body weight of nondiabetic hypercholesterolemic subjects.
    Burstein J; Jakobson T; Lindell KA; Nikiforow RE
    Ann Med Intern Fenn; 1968; 57(1):15-21. PubMed ID: 5726760
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of a new oral hypoglycemic product (glibenclamide-phenformin) on some aspects of lipid metabolism].
    Ceruso D; Squadrito G; Emanuele M; Quartarone M; Bellinghieri G
    Boll Soc Ital Biol Sper; 1973 Nov; 49(22):1285-9. PubMed ID: 4212680
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypolipidemic effects of metformin in hyperprebetalipoproteinemia.
    Fedele D; Tiengo A; Nosadini R; Marchiori E; Briani G; Garotti MC; Muggeo M
    Diabete Metab; 1976 Sep; 2(3):127-33. PubMed ID: 188698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
    Vogelberg KH
    Dtsch Med Wochenschr; 1976 Dec; 101(51):1868-71. PubMed ID: 1001205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin secretion and hydrocarbon tolerance in essential obesity in women (influence of fenfluramine, phenformin and D-amphetamine)].
    Cabezas Cerrato J; Catalán E; Vila T; Fernández-Cruz A
    Rev Clin Esp; 1973 May; 129(4):337-42. PubMed ID: 4720279
    [No Abstract]   [Full Text] [Related]  

  • 12. [Xantinol-nicotinate in primary type-V hyperlipoproteinaemia (author's transl)].
    Haacke H; Parwaresch MR; Mäder C
    Dtsch Med Wochenschr; 1976 Sep; 101(39):1413-7. PubMed ID: 185036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phenformin treatment of arteriosclerotic patients: changes induced in the plasma lipid picture. Preliminary note].
    Negri AU; Matteoli E; Zaini GF; Riva D
    Minerva Med; 1971 Nov; 62(89):4405-12. PubMed ID: 5162252
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipid, glucose, and insulin interrelationships in normal, prediabetic, and chemical diabetic subjects.
    Kyner JL; Levy RI; Soeldner JS; Gleason RE; Fredrickson DS
    J Lab Clin Med; 1976 Sep; 88(3):345-58. PubMed ID: 956689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-relationship between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenethylbiguanide (phenformin).
    Kissebah AH; Adams PW; Wynn V
    Diabetologia; 1974 Apr; 10(2):119-30. PubMed ID: 4844187
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of the obese diabetic. A comparative study of placebo, sulfonylurea and phenformin.
    Abramson E; Arky RA
    Metabolism; 1967 Mar; 16(3):204-12. PubMed ID: 5336062
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glucose tolerance in the course of treating endogenous hypertriglyceridaemia (author's transl)].
    Vogelberg KH; Gries FA
    Dtsch Med Wochenschr; 1979 Jun; 104(22):808-14. PubMed ID: 456256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenformin therapy of chemical diabetes.
    Danowski TS; Sunder JH; Stephan T; Nolan S; Ohlsen PM; Ahmad U; Vidalon C; Wingert JP
    J Clin Pharmacol; 1974; 14(11-12):638-50. PubMed ID: 4140199
    [No Abstract]   [Full Text] [Related]  

  • 19. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical picture and treatment of insulin resistance in primary hyperlipoproteinaemia (author's transl)].
    Vogelberg KH; Gries FA; Dietel J
    Dtsch Med Wochenschr; 1973 Sep; 98(38):1751-8. PubMed ID: 4355086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.